Nongenetic risk factors for thyroid cancer: an umbrella review of evidence.

IF 3.7 3区 医学 Q2 Medicine
Ge Peng, Xiaohui Pan, Ziwei Ye, Xianyanling Yi, Qingxing Xie, Xinyi Zhang, Nanwei Tong
{"title":"Nongenetic risk factors for thyroid cancer: an umbrella review of evidence.","authors":"Ge Peng, Xiaohui Pan, Ziwei Ye, Xianyanling Yi, Qingxing Xie, Xinyi Zhang, Nanwei Tong","doi":"10.1007/s12020-024-04155-x","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The incidence of thyroid cancer has increased annually, but the risk factors for thyroid cancer are still unclear. In this umbrella review, we aimed to identify associations between nongenetic risk factors and thyroid cancer incidence, and assess the quality and validity of the evidence.</p><p><strong>Methods: </strong>PubMed, Embase and the Cochrane Database of Systematic Reviews were searched to identify related meta-analyses or systematic reviews of epidemiological studies. We extracted the estimated summary effect and 95% confidence interval (CI) through fixed or random effects models of each meta-analysis. AMSTAR2 and the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) were used to evaluate the methodological quality of the included meta-analyses and the quality of evidence respectively. Further subgroup analyses by sex and sensitivity analyses were conducted.</p><p><strong>Results: </strong>We identified 53 articles with 112 associations, of which 69 had significant relationships with thyroid cancer risk, including factors related to iodine, nitrates, fish, vitamin D, tea, alcohol, smoke, body mass index (BMI), pesticides, X-ray, I<sup>131</sup>, oral contraceptives, flavonoids, reproductive factors and some medical conditions. However, most studies (65%) were categorized as \"critically low\" on the basis of AMSTAR2, and most evidence (86%) was of weak quality since the classification by GRADE was very low. Moreover, subgroup and sensitivity analyses revealed more risk factors in women than in men.</p><p><strong>Conclusion: </strong>We found that several modifiable factors have essential effects in the primary prevention of thyroid cancer, but few high-quality studies exist. In the future, more well-conducted, especially prospective, studies are needed to confirm the results.</p><p><strong>Trial registration: </strong>The protocol for this review was registered in PROSPERO (CRD42022352841).</p>","PeriodicalId":11572,"journal":{"name":"Endocrine","volume":" ","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2025-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Endocrine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12020-024-04155-x","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The incidence of thyroid cancer has increased annually, but the risk factors for thyroid cancer are still unclear. In this umbrella review, we aimed to identify associations between nongenetic risk factors and thyroid cancer incidence, and assess the quality and validity of the evidence.

Methods: PubMed, Embase and the Cochrane Database of Systematic Reviews were searched to identify related meta-analyses or systematic reviews of epidemiological studies. We extracted the estimated summary effect and 95% confidence interval (CI) through fixed or random effects models of each meta-analysis. AMSTAR2 and the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) were used to evaluate the methodological quality of the included meta-analyses and the quality of evidence respectively. Further subgroup analyses by sex and sensitivity analyses were conducted.

Results: We identified 53 articles with 112 associations, of which 69 had significant relationships with thyroid cancer risk, including factors related to iodine, nitrates, fish, vitamin D, tea, alcohol, smoke, body mass index (BMI), pesticides, X-ray, I131, oral contraceptives, flavonoids, reproductive factors and some medical conditions. However, most studies (65%) were categorized as "critically low" on the basis of AMSTAR2, and most evidence (86%) was of weak quality since the classification by GRADE was very low. Moreover, subgroup and sensitivity analyses revealed more risk factors in women than in men.

Conclusion: We found that several modifiable factors have essential effects in the primary prevention of thyroid cancer, but few high-quality studies exist. In the future, more well-conducted, especially prospective, studies are needed to confirm the results.

Trial registration: The protocol for this review was registered in PROSPERO (CRD42022352841).

甲状腺癌的非遗传危险因素:证据综述。
背景:甲状腺癌的发病率逐年上升,但甲状腺癌的危险因素尚不清楚。在本综述中,我们旨在确定非遗传危险因素与甲状腺癌发病率之间的关联,并评估证据的质量和有效性。方法:检索PubMed、Embase和Cochrane系统评价数据库,以确定流行病学研究的相关荟萃分析或系统评价。我们通过每个元分析的固定或随机效应模型提取估计的总效应和95%置信区间(CI)。采用AMSTAR2和推荐、评估、发展和评价分级(GRADE)分别评价纳入meta分析的方法学质量和证据质量。进一步进行了性别亚组分析和敏感性分析。结果:我们共鉴定出53篇文章,涉及112项关联,其中69项与甲状腺癌风险显著相关,包括与碘、硝酸盐、鱼类、维生素D、茶、酒精、吸烟、体重指数(BMI)、农药、x射线、I131、口服避孕药、类黄酮、生殖因素和一些医疗条件相关的因素。然而,大多数研究(65%)在AMSTAR2的基础上被归类为“极低”,大多数证据(86%)质量较弱,因为按GRADE分类非常低。此外,亚组分析和敏感性分析显示,女性的危险因素多于男性。结论:我们发现几个可改变的因素在甲状腺癌的一级预防中起重要作用,但缺乏高质量的研究。在未来,需要进行更多的研究,特别是前瞻性的研究来证实这些结果。试验注册:本综述的方案在PROSPERO注册(CRD42022352841)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Endocrine
Endocrine 医学-内分泌学与代谢
CiteScore
6.40
自引率
5.40%
发文量
0
期刊介绍: Well-established as a major journal in today’s rapidly advancing experimental and clinical research areas, Endocrine publishes original articles devoted to basic (including molecular, cellular and physiological studies), translational and clinical research in all the different fields of endocrinology and metabolism. Articles will be accepted based on peer-reviews, priority, and editorial decision. Invited reviews, mini-reviews and viewpoints on relevant pathophysiological and clinical topics, as well as Editorials on articles appearing in the Journal, are published. Unsolicited Editorials will be evaluated by the editorial team. Outcomes of scientific meetings, as well as guidelines and position statements, may be submitted. The Journal also considers special feature articles in the field of endocrine genetics and epigenetics, as well as articles devoted to novel methods and techniques in endocrinology. Endocrine covers controversial, clinical endocrine issues. Meta-analyses on endocrine and metabolic topics are also accepted. Descriptions of single clinical cases and/or small patients studies are not published unless of exceptional interest. However, reports of novel imaging studies and endocrine side effects in single patients may be considered. Research letters and letters to the editor related or unrelated to recently published articles can be submitted. Endocrine covers leading topics in endocrinology such as neuroendocrinology, pituitary and hypothalamic peptides, thyroid physiological and clinical aspects, bone and mineral metabolism and osteoporosis, obesity, lipid and energy metabolism and food intake control, insulin, Type 1 and Type 2 diabetes, hormones of male and female reproduction, adrenal diseases pediatric and geriatric endocrinology, endocrine hypertension and endocrine oncology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信